Advanced biomedicine, aimed at eliminating the root causes of diseases and providing personalized treatment through cell and gene therapy,
and aging research, aimed at accelerating the development of anti-aging therapies by accurately calculating the biological age, are considered to be
core biotechnologies that will save humanity and promising technologies that will shape the future.

In line with this trend, a conference has been organized to provide a platform for academic exchanges in the fields of high-tech biomedicine
and anti-aging to lay the groundwork for solving national challenges in the bio sector and leading the bio transformation.

The Korea Research Institute of Bioscience and Biotechnology (KRIBB) announced its plans to hold the 2023 KRIBB Annual Conference on
December 5. Under the slogan, "Advanced Biomedicine & Aging, Opening New Horizon of Future Biotechnology,"
the conference will feature a keynote lecture by KAIST Vice President for Research Lee Sang-yup, who founded the field of systems metabolic engineering,
followed by a broad range of discussions among experts on advanced biomedicine and anti-aging research.

A variety of other programs will also be organized for KRIBB to share the major research achievements
from the year 2023 and enable practical exchanges among the attendees.

In his opening remarks, Kim Jang-sung, President of KRIBB, said, “As biotech emerges as a game changer in the global technology landscape,
competition among nations to secure advanced biotechnologies is intensifying, and amid these circumstances,
the Korea Research Institute of Bioscience and Biotechnology will endeavor to secure super gap technologies
by undertaking challenging and innovative R&D to serve as a leader in tackling national challenges and spearhead the bio transformation.”